Efficacy and safety of first-line ibrutinib plus venetoclax in patients with mantle cell lymphoma (MCL) who were older or had

Authors: Michael Wang, Marc S. Hoffmann, Tomasz Wrobel, Marek Trneny, David Belada, Fatih Demirkan, Panayiotis Panayiotidis, Wojciech Jurczak, Pier Luigi Zinzani, Mary-Margaret Keating, Sung-Soo Yoon, Miklos Egyed, Constantine Si Lun Tam, Nathalie Johnson, Edith Szafer-Glusman, Jennifer Lin, James P. Dean, Jutta Katrin Neuenburg, Gottfried von Keudell

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.7017

Source: Full article

---

Abstract

7017